Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Elaine Au"'
Autor:
Lawrence Chun Man Lau, Ping Keung Chan, Tak Wai David Lui, Siu Wai Choi, Elaine Au, Thomas Leung, Michelle Hilda Luk, Amy Cheung, Henry Fu, Man Hong Cheung, Kwong Yuen Chiu
Publikováno v:
Arthroplasty, Vol 6, Iss 1, Pp 1-11 (2024)
Abstract Background The high co-prevalence of obesity and end-stage osteoarthritis requiring arthroplasty, with the former being a risk factor for complications during arthroplasty, has led to increasing interest in employing preoperative weight loss
Externí odkaz:
https://doaj.org/article/4d4c04545b0b49a68118a926cdffb306
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Here we compared clonotype identification by allele-specific oligonucleotide real-time quantitative-PCR (ASO RQ-PCR) and next-generation sequencing (NGS) in 80 multiple myeloma patients. ASO RQ-PCR was applicable in 49/55 (89%) and NGS in 62/78 (80%)
Externí odkaz:
https://doaj.org/article/d7e1321a42ff4a0c868eb821a207ba0d
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 7, Pp n/a-n/a (2020)
Abstract Objectives Complete C6 deficiency (C6Q0) is a rare primary immunodeficiency leading to increased susceptibility to recurrent Neisseria infections. Patients with C6Q0 have mostly been reported in individuals of African ancestry previously, bu
Externí odkaz:
https://doaj.org/article/1e357e790a094ac4bc340c17ae7f0a3d
Identification and Mapping of a 2,009-bp DNA Deletion in SERPING1 of a Hereditary Angioedema Patient
Publikováno v:
Case Reports in Genetics, Vol 2019 (2019)
We report a heterozygous, 2,009 base pairs (bps) genomic DNA deletion within the SERPING1 gene that has not previously been reported in a case of type I hereditary angioedema (HAE). The patient is a 28-year-old Han Chinese female living in Hong Kong
Externí odkaz:
https://doaj.org/article/f5d14e79eebd46768eb504923026239b
Background: Longitudinal whole-population studies can explore new dimensions in drug allergy research. Excipient allergy testing remains a barrier to allergy evaluation in countries without legislations mandating ingredient disclosure in registered d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a459a4215c352ddf287a2df61378dba2
https://doi.org/10.22541/au.168179417.75319603/v1
https://doi.org/10.22541/au.168179417.75319603/v1
Autor:
Daniel Leung, Xiaofeng Mu, Jaime Rosa Duque, Samuel Cheng MS, Manni Wang, Wenyue Zhang, Yanmei Zhang, Issan Tam YS, Toby Lee SS, Jennifer Lam HY, Sau Man Chan, Cheuk Hei Cheang, Yuet Chung, Howard Wong HW, Amos Lee MT, Wing Yan Li, Sara Chaothai, Leo Tsang CH, Gilbert T Chua, Kai-Ning Cheong, Elaine Au, Janette Kwok SY, Koon Wing Chan, Patrick Chong, Pamela Lee, Marco HK Ho, Tsz Leung Lee, Tu WW, Malik Peiris, YL Lau
Background Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in adult and pediatric patients with inborn errors of immunity (IEIs) remain unknown. Intradermal vaccination may improve immunogenicity in immunocompromised patients. Our stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d05695ea9550ab3e427aa49a1a7ae2f
https://doi.org/10.22541/au.165629347.75546543/v1
https://doi.org/10.22541/au.165629347.75546543/v1
Publikováno v:
Pathology. 55:S37
Publikováno v:
Pathology. 55:S98
Autor:
Chi Kuen Lau, Bonnie Kho, Eric Tse, Yok-Lam Kwong, Chor Sang Chim, Yu-Yan Hwang, Elaine Au, Hoi Ki Karen Tang, Joycelyn Sim, Kwan Hung Leung, Sze Fai Yip, Harold K. K. Lee, Chi Yeung Fung, Howard Wong
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S136-S137
Background Autologous stem cell transplant (ASCT) is the standard of care for eligible patients with newly diagnosed multiple myeloma (NDMM). In Hong Kong, NDMM received bortezomib-based triplet induction. NDMM ≤65 years of age were considered tran
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology, Vol 10 (2021)
Here we compared clonotype identification by allele-specific oligonucleotide real-time quantitative-PCR (ASO RQ-PCR) and next-generation sequencing (NGS) in 80 multiple myeloma patients. ASO RQ-PCR was applicable in 49/55 (89%) and NGS in 62/78 (80%)